Standard of Care Therapy With or Without Stereotactic Radiosurgery and/or Surgery in Treating Patients With Limited Metastatic Breast Cancer



Status:Recruiting
Conditions:Breast Cancer, Cancer, Chronic Pain, Other Indications, Pulmonary
Therapuetic Areas:Musculoskeletal, Oncology, Pulmonary / Respiratory Diseases, Other
Healthy:No
Age Range:18 - Any
Updated:1/30/2019
Start Date:December 24, 2014
End Date:December 31, 2027

Use our guide to learn which trials are right for you!

A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer

This randomized phase II/III trial studies how well standard of care therapy with
stereotactic radiosurgery and/or surgery works and compares it to standard of care therapy
alone in treating patients with breast cancer that has spread to one or two locations in the
body (limited metastatic) that are previously untreated. Standard of care therapy comprising
chemotherapy, hormonal therapy, biological therapy, and others may help stop the spread of
tumor cells. Radiation therapy and/or surgery is usually only given with standard of care
therapy to relieve pain; however, in patients with limited metastatic breast cancer,
stereotactic radiosurgery, also known as stereotactic body radiation therapy, may be able to
send x-rays directly to the tumor and cause less damage to normal tissue and surgery may be
able to effectively remove the metastatic tumor cells. It is not yet known whether standard
of care therapy is more effective with stereotactic radiosurgery and/or surgery in treating
limited metastatic breast cancer.

PRIMARY OBJECTIVES:

I. To determine whether ablation (through stereotactic body radiation therapy [SBRT]
[stereotactic radiosurgery] and/or surgical resection of all known metastases) in
oligometastatic breast cancer patients provides a sufficient signal for improved
progression-free survival (PFS) to warrant full accrual to the Phase III portion of the
trial. (Phase II-R) II. To determine whether ablation (through SBRT and/or surgical resection
of all known metastases) in oligometastatic breast cancer patients significantly improves
overall survival (OS). (Phase III)

SECONDARY OBJECTIVES:

I. To evaluate treated metastasis control according to tumor receptor status (estrogen
receptor [ER], progesterone receptor [PR], human epidermal growth factor receptor [HER]-2),
use of chemotherapy, surgery vs. ablative therapy, and solitary metastasis vs. 2 metastasis
(may expand to >= 2 to =< 4 following completion of a Phase I trial).

II. To evaluate whether the addition of ablative metastasis directed therapy significantly
reduces the number of distant recurrences (new metastases) in patients who progress according
to tumor receptor status (ER, PR, HER-2); use of chemotherapy, and solitary metastasis vs. 2
metastases (may expand to >= 2 to =< 4 following completion of the Phase I NRG-BR001 trial).

III. To evaluate adverse events in patients who receive ablative metastasis-directed therapy
to all known metastases in addition to standard medical therapy alone.

IV. To explore the most appropriate and clinically relevant technological parameters to
ensure quality and effectiveness throughout the radiation therapy processes, including
imaging, simulation, target and critical structure definition, treatment planning, image
guidance, and delivery.

TERTIARY OBJECTIVES:

I. To determine whether < 5 circulating tumor cells (CTCs) (per 7.5 ml of blood) is an
independent prognostic (outcome) marker for improved PFS and OS in oligometastatic breast
cancer.

II. To determine whether < 5 CTCs (per 7.5 ml of blood) is an independent predictive
(response to therapy) marker for improved PFS and OS in oligometastatic breast cancer.

III. To determine whether eliminating CTCs (0/7.5 ml of blood in patients with at least 2
CTCs at registration) is both a prognostic and predictive marker for improved PFS and OS.

IV. To evaluate the prognostic and predictive properties of CTC count as a continuous measure
of PFS and OS.

V. To store material for retrospective analysis of circulating tumor deoxyribonucleic acid
(ctDNA).

VI. To store material for retrospective analysis of circulating micro-ribonucleic acid (RNA).

OUTLINE: Patients are randomized to 1 of 2 treatment arms.

ARM 1: Patients continue to receive their current planned systemic therapy at the discretion
of the treating physician.

ARM 2: Patients continue to receive their current planned systemic therapy at the discretion
of the treating physician. Patients also undergo stereotactic radiosurgery in 1, 3, or 5
fractions within 3 weeks and/or surgery at the discretion of the treating physician.

ARM 1: Patients are followed every 3 months from randomization to 2 years. ARM 2: Patients
are followed 25-35 days post-ablation, every 3 months from randomization to 2 years, and then
yearly thereafter.

Inclusion Criteria:

- Pathologically confirmed metastatic breast cancer

- Known estrogen, progesterone, and HER2 status of either primary tumor or metastasis

- ≤ 4 metastases seen on standard imaging within 60 days prior to registration when all
metastatic disease is located within the following sites:

- peripheral lung

- osseous (bone)

- spine

- central lung

- abdominal-pelvic(lymph node/adrenal gland)

- liver

- mediastinal/cervical lymph node

- All known disease amenable to metastasis-directed therapy with either SBRT or
resection

- NOTE: Symptomatic bone metastasis are allowed if ablative therapy can be
delivered

- NOTE: Sites for possible surgical excision include lung, liver, adrenal gland,
bone, small intestine, large intestine, ovary, and amenable nodal disease sites

- NOTE: Surgical stabilization is allowed for a metastasis if it is followed by
conventionally fractionated external beam radiotherapy

- Maximum diameter of individual metastasis in any dimension ≤ 5 cm

- There are no restrictions on distance between the metastases

- Patients must be registered within 365 days of the initial metastatic breast cancer
diagnosis. First-line standard systemic therapy (chemotherapy, anti-endocrine therapy,
anti-HER2 or other standard targeted therapy) for metastatic breast cancer must be
given or planned to be given. If given before study entry, it cannot have exceeded a
duration of 12 months at the time of registration. (Note: Sequencing of ablative
therapy (surgery or SBRT) relative to systemic therapy, for patients randomized to Arm
2, is at the discretion of the treating physician.)

- The primary tumor site must be controlled prior to registration

- For those who present with synchronous primary and oligometastatic disease:

Primary must be controlled prior to registration. The definition of control is definitive
surgery by excision or mastectomy (+/- radiotherapy) per institution preference

- For those who present with local recurrence and oligometastatic disease, local
recurrence must be controlled prior to registration The definition of control is
definitive surgery by excision or mastectomy (+/- radiotherapy) per institution
preference

- Appropriate stage for study entry based on the following diagnostic workup:

- History/physical examination within 60 days prior to registration

- Clinical grade computed tomography (CT) scans of the chest, abdomen, and pelvis with
radionuclide bone scan OR whole body positron emission tomography (PET)/CT within 60
days prior to study registration

- Zubrod performance status ≤ 2 within 60 days prior to registration

- Absolute neutrophil count (ANC) ≥ 500 cells/mm^3

- Platelets ≥ 50,000 cells/mm^3

- Hemoglobin ≥ 8.0 g/dl (note: the use of transfusion or other intervention to
achieve hemoglobin [Hgb] ≥ 8.0 g/dl is acceptable)

- For females of child-bearing potential, negative serum or urine pregnancy test
within 14 days prior to study registration

Exclusion Criteria:

- Pathologic evidence of local/regional breast tumor recurrence at the time of
registration

- Co-existing or prior invasive malignancy (except non-melanomatous skin cancer), unless
disease free for a minimum of 3 years; previous RT dose, date, fraction size, must be
reported

- Metastases with indistinct borders making targeting not feasible

- NOTE: A potential issue with bone metastases is that they often are not discrete.
Since many patients on this protocol will have bone metastases, this will be an
important issue. Theoretically, Houndsfield units might provide an appropriate
measure; however, a sclerotic lesion against dense cortical bone will not have a
sharp demarcation based on Houndsfield units (HU). Therefore, we acknowledge that
such determinations will pose a challenge and thus the physician's judgment will
be required

- Prior palliative radiation treatment for metastatic disease (including
radiopharmaceuticals)

- Metastases located within 3 cm of the previously irradiated structures:

- Spinal cord previously irradiated to > 40 Gy (delivered in ≤ 3 Gy/fraction)

- Brachial plexus previously irradiated to > 50 Gy (delivered in ≤ 3 Gy/fraction)

- Small intestine, large intestine, or stomach previously irradiated to > 45 Gy
(delivered in ≤ 3 Gy/fraction)

- Brainstem previously irradiated to > 50 Gy (delivered in ≤ 3 Gy/fraction)

- Whole lung previously irradiated with prior V20Gy > 30% (delivered in ≤ 3
Gy/fraction)

- Primary tumor irradiated with SBRT

- Metastasis irradiated with SBRT

- Brain metastases

- Exudative, bloody, or cytological proven malignant effusions

- Severe, active co-morbidity defined as follows:

- Unstable angina and/or congestive heart failure requiring hospitalization within
the last 6 months

- Transmural myocardial infarction within the last 6 months

- Acute bacterial or fungal infection requiring intravenous antibiotics at the time
of registration

- Chronic obstructive pulmonary disease exacerbation or other respiratory illness
requiring hospitalization or precluding study therapy at the time of registration

- Pregnancy; lactating females must cease expression of milk prior to signing consent to
be eligible

- Human immunodeficiency virus (HIV) positive with cluster of differentiation (CD)4
count < 200 cells/microliter; note that patients who are HIV positive are eligible,
provided they are under treatment with highly active antiretroviral therapy (HAART)
and have a CD4 count ≥ 200 cells/microliter within 30 days prior to registration; note
also that HIV testing is not required for eligibility for this protocol
We found this trial at
136
sites
4500 San Pablo Rd S
Jacksonville, Florida 32224
(904) 953-2000
Principal Investigator: Kimberly S. Corbin
Phone: 855-776-0015
Mayo Clinic Florida Thousands of people come to Mayo Clinic in Jacksonville, Fla., annually for...
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
1201 Camino de Salud Northeast
Albuquerque, New Mexico 87131
(505) 272-4946
Principal Investigator: Gregory N. Gan
Phone: 505-925-0366
University of New Mexico Cancer Center It’s been 40 years since the New Mexico State...
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
3300 Gallows Road
Falls Church, Virginia 22042
(703) 776-4001
Principal Investigator: Ashish K. Chawla
Phone: 703-208-6650
Inova Fairfax Hospital Inova Fairfax Hospital, Inova's flagship hospital, is an 833-bed, nationally recognized regional...
?
mi
from
Falls Church, VA
Click here to add this to my saved trials
8700 Beverly Blvd # 8211
Los Angeles, California 90048
(1-800-233-2771)
Principal Investigator: Mitchell R. Kamrava
Phone: 310-423-8965
Cedars Sinai Med Ctr Cedars-Sinai is known for providing the highest quality patient care. Our...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
4805 Northeast Glisan Street
Portland, Oregon 97213
(503) 215-1111
Principal Investigator: Benjamin B. Bridges
Phone: 503-215-2614
Providence Portland Medical Center We strive to give those we serve exceptional, compassionate health care...
?
mi
from
Portland, OR
Click here to add this to my saved trials
60 Crittenden Blvd # 70
Rochester, New York 14642
(585) 275-2121
Principal Investigator: Yuhchyau Chen
Phone: 585-275-5830
University of Rochester The University of Rochester is one of the country's top-tier research universities....
?
mi
from
Rochester, NY
Click here to add this to my saved trials
34800 Bob Wilson Dr,
San Diego, California 92134
(619) 532-6400
Principal Investigator: Harvey B. Wilds
Phone: 619-532-8712
Naval Medical Center - San Diego We are the largest and most comprehensive military healthcare...
?
mi
from
San Diego, CA
Click here to add this to my saved trials
1 Akron General Avenue
Akron, Ohio 44307
Principal Investigator: Mitchel L. Fromm
Phone: 866-223-8100
?
mi
from
Akron, OH
Click here to add this to my saved trials
Albuquerque, New Mexico 87109
Principal Investigator: Gregory N. Gan
Phone: 505-272-0530
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Albuquerque, New Mexico 87102
Principal Investigator: Gregory N. Gan
Phone: 505-272-0530
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
4650 Jefferson Lane Northeast
Albuquerque, New Mexico 87109
Principal Investigator: Gregory N. Gan
Phone: 505-272-0530
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Anderson, Indiana 46016
Principal Investigator: Alexander M. Yeh
Phone: 317-338-2194
?
mi
from
Anderson, IN
Click here to add this to my saved trials
1500 East Medical Center Drive
Ann Arbor, Michigan 48109
800-865-1125
Principal Investigator: Reshma Jagsi
University of Michigan Comprehensive Cancer Center The U-M Comprehensive Cancer Center's mission is the conquest...
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
550 Peachtree St NE
Atlanta, Georgia 30308
(404) 686-4411
Principal Investigator: Shannon T. Kahn
Phone: 888-946-7447
Emory University Hospital Midtown Emory University Hospital Midtown is a 511-bed community-based, acute care teaching...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
1968 Peachtree Rd NW
Atlanta, Georgia 30309
(404) 605-5000
Principal Investigator: Adam Nowlan, MD
Phone: 404-605-4924
Piedmont Hospital For more than a century, Piedmont Healthcare has been a recognized leader in...
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Atlanta, Georgia 30322
Principal Investigator: Shannon T. Kahn
Phone: 404-778-1868
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Atlanta, Georgia 30342
Principal Investigator: Shannon T. Kahn
Phone: 412-339-5294
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
12605 East 16th Avenue
Aurora, Colorado 80045
720-848-0000
Principal Investigator: Rachel A. Rabinovitch
Phone: 720-848-0650
University of Colorado Hospital, Site Top medical professionals, superior medicine and progressive change make University...
?
mi
from
Aurora, CO
Click here to add this to my saved trials
Austin, Texas 78705
?
mi
from
Austin, TX
Click here to add this to my saved trials
22 South Greene Street
Baltimore, Maryland 21201
410-328-7904
Principal Investigator: Sally B. Cheston
Phone: 800-888-8823
University of Maryland Greenebaum Cancer Center The University of Maryland Marlene and Stewart Greenebaum Cancer...
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
Bel Air, Maryland 21014
Principal Investigator: Jack J. Hong
Phone: 443-643-3010
?
mi
from
Bel Air, MD
Click here to add this to my saved trials
Berkeley, California 94704
Principal Investigator: Oleg I. Krijanovski
Phone: 415-209-2686
?
mi
from
Berkeley, CA
Click here to add this to my saved trials
Biddeford, Maine 04005
Principal Investigator: Matthew D. Cheney
?
mi
from
Biddeford, ME
Click here to add this to my saved trials
Birmingham, Alabama 35233
Principal Investigator: Jennifer F. De Los Santos
Phone: 205-934-0220
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
300 N. Seventh St.
Bismarck, North Dakota 58501
(701) 323-6000
Sanford Bismarck Medical Center Whether your stay in our hospital is one day for same...
?
mi
from
Bismarck, ND
Click here to add this to my saved trials
Bronx, New York 10467
Principal Investigator: Jana L. Fox
Phone: 718-904-2730
?
mi
from
Bronx, NY
Click here to add this to my saved trials
Brownstown, Michigan 48183
Principal Investigator: Eleanor M. Walker
Phone: 412-339-5294
?
mi
from
Brownstown, MI
Click here to add this to my saved trials
Burlington, Massachusetts 01805
Principal Investigator: Andrea B. McKee
Phone: 781-744-8027
?
mi
from
Burlington, MA
Click here to add this to my saved trials
Calgary, Alberta
Principal Investigator: Tien Phan
Phone: 403-521-3433
?
mi
from
Calgary,
Click here to add this to my saved trials
150 Parkway Office Court
Cary, North Carolina 27518
Principal Investigator: Achilles J. Fakiris
Phone: 919-784-7209
?
mi
from
Cary, NC
Click here to add this to my saved trials
Chapel Hill, North Carolina 27599
Principal Investigator: Lawrence B. Marks
Phone: 877-668-0683
?
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
303 East Superior Street
Chicago, Illinois 60611
Principal Investigator: Jonathan B. Strauss
Phone: 312-695-1301
?
mi
from
Chicago, IL
Click here to add this to my saved trials
1200 West Harrison Stree
Chicago, Illinois 60607
(312) 996-4350
Principal Investigator: Kent F. Hoskins
Phone: 312-355-3046
Univ of Illinois A major research university in the heart of one of the world's...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
1653 W. Congress Parkway
Chicago, Illinois 60612
(312) 942-5000
Principal Investigator: Parul N. Barry
Phone: 312-942-5498
Rush University Medical Center Rush University Medical Center encompasses a 664-bed hospital serving adults and...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
5841 S Maryland Ave
Chicago, Illinois 60637
1-773-702-6180
Principal Investigator: Steven J. Chmura
Phone: 773-702-8222
University of Chicago Comprehensive Cancer Center The University of Chicago Comprehensive Cancer Center (UCCCC) is...
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Clarkston, Michigan 48346
Principal Investigator: Frank A. Vicini
Phone: 248-338-0663
?
mi
from
Clarkston, MI
Click here to add this to my saved trials
10900 Euclid Ave
Cleveland, Ohio 44106
216-368-2000
Principal Investigator: Eleanor E. Harris
Phone: 800-641-2422
Case Western Reserve Univ Continually ranked among America's best colleges, Case Western Reserve University has...
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
Clinton Township, Michigan 48038
Principal Investigator: Eleanor M. Walker
Phone: 313-916-1784
?
mi
from
Clinton Township, MI
Click here to add this to my saved trials
6001 E Woodmen Rd
Colorado Springs, Colorado 80923
(719) 776-5000
Principal Investigator: Richard L. Deming
Phone: 308-398-6518
Penrose-Saint Francis Healthcare Founded by the Sisters of St. Francis and the Sisters of Charity,...
?
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
1400 East Boulder Street
Colorado Springs, Colorado 80909
?
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Columbia, Maryland 21044
Principal Investigator: Sally B. Cheston
Phone: 443-546-1300
?
mi
from
Columbia, MD
Click here to add this to my saved trials
Columbus, Ohio 43210
Principal Investigator: Jose G. Bazan
Phone: 800-293-5066
?
mi
from
Columbus, OH
Click here to add this to my saved trials
4050 Coon Rapids Blvd NW
Coon Rapids, Minnesota 55433
(763) 236-6000
Principal Investigator: Paul W. Sperduto
Phone: 952-993-1517
Mercy Hospital Mercy Hospital, located in Coon Rapids, Minnesota, is a 271-bed non-profit hospital that...
?
mi
from
Coon Rapids, MN
Click here to add this to my saved trials
Dallas, Texas 75390
Principal Investigator: Asal S. Rahimi
Phone: 214-648-7097
?
mi
from
Dallas, TX
Click here to add this to my saved trials
2300 N Edward St
Decatur, Illinois 62526
(217) 876-8121
Principal Investigator: Bryan A. Faller
Phone: 217-876-4740
Decatur Memorial Hospital An American flag bearing only 48 stars waved above Decatur Memorial Hospital...
?
mi
from
Decatur, IL
Click here to add this to my saved trials
2799 W Grand Blvd
Detroit, Michigan 48202
(313) 916-2600
Principal Investigator: Eleanor M. Walker
Phone: 313-916-1784
Henry Ford Hospital Founded in 1915 by auto pioneer Henry Ford and now one of...
?
mi
from
Detroit, MI
Click here to add this to my saved trials
Dover, New Hampshire 03820
Principal Investigator: Arul Mahadevan
Phone: 603-740-2150
?
mi
from
Dover, NH
Click here to add this to my saved trials
Duluth, Minnesota 55805
Principal Investigator: Steven R. Bonin
Phone: 412-339-5294
?
mi
from
Duluth, MN
Click here to add this to my saved trials
2301 Erwin Rd
Durham, North Carolina 27710
919-684-8111
Principal Investigator: Joseph K. Salama
Phone: 888-275-3853
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
?
mi
from
Durham, NC
Click here to add this to my saved trials
28595 Orchard Lake Road
Farmington Hills, Michigan 48334
Principal Investigator: Frank A. Vicini
Phone: 248-338-0663
?
mi
from
Farmington Hills, MI
Click here to add this to my saved trials
1024 S Lemay Ave
Fort Collins, Colorado 80524
(970) 495-7000
Principal Investigator: Rachel A. Rabinovitch
Phone: 970-297-6150
Poudre Valley Hospital A 270-bed regional medical center offering a wide array of treatments, surgeries,...
?
mi
from
Fort Collins, CO
Click here to add this to my saved trials
2200 Randallia Drive
Fort Wayne, Indiana 46805
Principal Investigator: Brian K. Chang
Phone: 260-373-8888
?
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Fort Wayne, Indiana 46845
Principal Investigator: Brian K. Chang
Phone: 877-784-4673
?
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
1600 Southwest Archer Road
Gainesville, Florida 32610
?
mi
from
Gainesville, FL
Click here to add this to my saved trials
300 Health Park Drive
Garner, North Carolina 27529
Principal Investigator: Achilles J. Fakiris
Phone: 919-784-7209
?
mi
from
Garner, NC
Click here to add this to my saved trials
1117 29th St S
Great Falls, Montana 59405
(406) 771-7300
Principal Investigator: Benjamin T. Marchello
Phone: 406-969-6060
Benefis Healthcare- Sletten Cancer Institute Benefis Hospitals has 516 beds at its two campuses (that...
?
mi
from
Great Falls, MT
Click here to add this to my saved trials
835 S Van Buren St
Green Bay, Wisconsin 54301
Principal Investigator: Matthew L. Ryan
Phone: 920-433-8889
?
mi
from
Green Bay, WI
Click here to add this to my saved trials
1726 Shawano Avenue
Green Bay, Wisconsin 54303
Principal Investigator: Matthew L. Ryan
Phone: 412-339-5294
?
mi
from
Green Bay, WI
Click here to add this to my saved trials
Greenwood, South Carolina 29646
Principal Investigator: Jennifer L. Harper
Phone: 864-725-4771
?
mi
from
Greenwood, SC
Click here to add this to my saved trials
Greer, South Carolina 29651
Principal Investigator: Steven W. Corso
Phone: 864-560-6104
?
mi
from
Greer, SC
Click here to add this to my saved trials
24800 SE Stark St
Gresham, Oregon 97030
(503) 674-1122
Principal Investigator: Andrew Y. Kee
Phone: 503-413-2150
Legacy Mount Hood Medical Center Legacy Mount Hood Medical Center, East County's full-service community hospital,...
?
mi
from
Gresham, OR
Click here to add this to my saved trials
4300 Londonderry Road
Harrisburg, Pennsylvania 17109
Principal Investigator: Dwight E. Heron
Phone: 717-724-6765
?
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Hollywood, Florida 33021
Principal Investigator: Srinath Sundararaman
Phone: 888-823-5923
?
mi
from
Hollywood, FL
Click here to add this to my saved trials
1301 Punchbowl St
Honolulu, Hawaii 96813
(808) 538-9011
Principal Investigator: Kenneth N. Sumida
Phone: 412-339-5294
Queen's Medical Center The Queen's Medical Center, located in downtown Honolulu, Hawaii, is a private,...
?
mi
from
Honolulu, HI
Click here to add this to my saved trials
Houston, Texas 77030
Principal Investigator: Wendy A. Woodward
Phone: 877-312-3961
?
mi
from
Houston, TX
Click here to add this to my saved trials
Huntington, West Virginia 25701
Principal Investigator: Maria R. Tria Tirona
Phone: 304-399-6617
?
mi
from
Huntington, WV
Click here to add this to my saved trials
310 Sunnyview Ln
Kalispell, Montana 59901
(406) 752-5111
Principal Investigator: Benjamin T. Marchello
Phone: 406-969-6060
Kalispell Regional Medical Center Nestled in the beautiful Flathead Valley of Northwestern Montana, Kalispell Regional...
?
mi
from
Kalispell, MT
Click here to add this to my saved trials
La Crosse, Wisconsin
Principal Investigator: Collin D. Driscoll
Phone: 608-775-2385
?
mi
from
La Crosse, WI
Click here to add this to my saved trials
3855 Health Sciences Dr,
La Jolla, California 92093
(858) 822-6100
Principal Investigator: James Urbanic, MD
Phone: 858-246-0500
UC San Diego Moores Cancer Center Established in 1978, UC San Diego Moores Cancer Center...
?
mi
from
La Jolla, CA
Click here to add this to my saved trials
1 Medical Center Dr
Lebanon, New Hampshire 03756
 (603) 650-5000
Principal Investigator: Lesley A. Jarvis
Phone: 800-639-6918
Dartmouth Hitchcock Medical Center Dartmouth-Hitchcock is a national leader in patient-centered health care and building...
?
mi
from
Lebanon, NH
Click here to add this to my saved trials
1441 Eastlake Ave
Los Angeles, California 90033
(323) 865-3000
Principal Investigator: Jason C. Ye
Phone: 323-865-0451
U.S.C./Norris Comprehensive Cancer Center The USC Norris Comprehensive Cancer Center, located in Los Angeles, is...
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
2000 N Boise Ave
Loveland, Colorado 80538
(970) 669-4640
Principal Investigator: Keren Sturtz
Phone: 303-777-2663
McKee Medical Center Through the years, McKee has led the way in health care innovation....
?
mi
from
Loveland, CO
Click here to add this to my saved trials
295 Varnum Ave
Lowell, Massachusetts 01854
(978) 937-6000
Principal Investigator: Matthew S. Katz
Phone: 978-788-7084
Lowell General Hospital Welcome to Lowell General Hospital! Our goal is to provide you with...
?
mi
from
Lowell, MA
Click here to add this to my saved trials
2160 South 1st Avenue
Maywood, Illinois 60153
(888) 584-7888
Principal Investigator: Abhishek A. Solanki
Phone: 708-226-4357
Loyola University Medical Center Loyola University Health System is committed to excellence in patient care...
?
mi
from
Maywood, IL
Click here to add this to my saved trials
9200 W Wisconsin Ave
Milwaukee, Wisconsin 53226
(414) 805-3666
Principal Investigator: Carmen R. Bergom
Phone: 414-805-4380
Froedtert and the Medical College of Wisconsin Froedtert Health combines with the Medical College of...
?
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Morgantown, West Virginia 26505
Principal Investigator: Geraldine M. Jacobson
Phone: 304-293-7374
?
mi
from
Morgantown, WV
Click here to add this to my saved trials
Mount Holly, New Jersey 08060
?
mi
from
Mount Holly, NJ
Click here to add this to my saved trials
Muncie, Indiana 47303
Principal Investigator: Yunjie X. Lin
Phone: 765-751-5850
?
mi
from
Muncie, IN
Click here to add this to my saved trials
New York, New York 10032
Principal Investigator: Eileen P. Connolly
Phone: 212-305-6361
?
mi
from
New York, NY
Click here to add this to my saved trials
Newark, Delaware 19713
Principal Investigator: Gregory A. Masters
Phone: 302-623-4450
?
mi
from
Newark, DE
Click here to add this to my saved trials
5475 South 500 East
Ogden, Utah 84405
Principal Investigator: Brandon J. Fisher
Phone: 412-339-5294
?
mi
from
Ogden, UT
Click here to add this to my saved trials
940 NE 13th St
Oklahoma City, Oklahoma 73190
(405) 271-6458
Principal Investigator: J. S. Thompson
Phone: 405-271-8777
University of Oklahoma Health Sciences Center The OU Health Sciences Center is composed of seven...
?
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Emile St
Omaha, Nebraska 68198
(402) 559-4000
Principal Investigator: Andrew O. Wahl
Phone: 402-559-6941
Univ of Nebraska Med Ctr A vital enterprise in the nation’s heartland, the University of...
?
mi
from
Omaha, NE
Click here to add this to my saved trials
Orange, California 92868
Principal Investigator: Parima Daroui
Phone: 877-827-8839
?
mi
from
Orange, CA
Click here to add this to my saved trials
Orlando, Florida 32806
Principal Investigator: Patrick Kelly
Phone: 321-841-7246
?
mi
from
Orlando, FL
Click here to add this to my saved trials
?
mi
from
Owensboro, KY
Click here to add this to my saved trials
Pembroke Pines, Florida 33028
Principal Investigator: Srinath Sundararaman
Phone: 954-265-4325
?
mi
from
Pembroke Pines, FL
Click here to add this to my saved trials
?
mi
from
Peoria, AZ
Click here to add this to my saved trials
Philadelphia, Pennsylvania 19104
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
320 E North Ave
Pittsburgh, Pennsylvania 15212
(412) 359-3131
Principal Investigator: Mark G. Trombetta
Phone: 877-284-2000
Allegheny General Hospital At Allegheny General Hospital, our physicians and healthcare staff have earned an...
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pontiac, Michigan 48341
Principal Investigator: Samir Narayan
Phone: 734-712-3671
?
mi
from
Pontiac, MI
Click here to add this to my saved trials
Portland, Maine 04102
Principal Investigator: Matthew D. Cheney
Phone: 207-885-7565
?
mi
from
Portland, ME
Click here to add this to my saved trials
1015 NW 22nd Ave
Portland, Oregon 97210
(503) 413-7711
Principal Investigator: Andrew Y. Kee
Phone: 800-220-4937
Legacy Good Samaritan Hospital and Medical Center Located in the heart of Northwest Portland, Legacy...
?
mi
from
Portland, OR
Click here to add this to my saved trials
Portland, Oregon 97225
Principal Investigator: Benjamin B. Bridges
Phone: 503-215-2614
?
mi
from
Portland, OR
Click here to add this to my saved trials
Raleigh, North Carolina 27609
Principal Investigator: Achilles J. Fakiris
Phone: 919-784-7209
?
mi
from
Raleigh, NC
Click here to add this to my saved trials
2605 Blue Ridge Road
Raleigh, North Carolina 27607
Principal Investigator: Achilles J. Fakiris
Phone: 919-784-7209
?
mi
from
Raleigh, NC
Click here to add this to my saved trials
Raleigh, North Carolina 27614
Principal Investigator: Achilles J. Fakiris
Phone: 919-784-7209
?
mi
from
Raleigh, NC
Click here to add this to my saved trials
Reno, Nevada 89502
Principal Investigator: Michael C. Hardacre
Phone: 702-384-0013
?
mi
from
Reno, NV
Click here to add this to my saved trials
Richmond, Virginia 23226
Principal Investigator: William J. Irvin
Phone: 412-339-5294
?
mi
from
Richmond, VA
Click here to add this to my saved trials
Rochester, Minnesota 55905
Principal Investigator: Kimberly S. Corbin
Phone: 855-776-0015
?
mi
from
Rochester, MN
Click here to add this to my saved trials
Roseville, California 95678
Principal Investigator: Samantha A. Seaward
Phone: 877-642-4691
?
mi
from
Roseville, CA
Click here to add this to my saved trials